Key Takeaways
- On April 7, Circle board member Rajeev Date offloaded 1,273 CRCL shares at $95 apiece, netting $120,935 through a predetermined Rule 10b5-1 trading arrangement
- Date’s stake decreased 0.83% to 152,328 shares, representing more than $14.4 million in current value
- The company exceeded Q4 earnings projections with $0.43 EPS versus the $0.25 forecast, while revenue reached $770.23 million—a 76.9% annual surge
- Compass Point issued a Sell recommendation with a $77 target price, warning of gross margin deterioration expected in the first half of 2026
- Wall Street consensus remains at Hold with a $126.29 average target; institutional players like Vanguard boosted their Q3 positions significantly
Circle Internet Group board member Rajeev Date divested 1,273 shares of CRCL stock on April 7, 2026. The transaction occurred at $95.00 per share, generating proceeds totaling $120,935.
This divestiture followed a Rule 10b5-1 predetermined trading arrangement, indicating the transaction was planned beforehand rather than prompted by immediate market developments. Date maintains ownership of 152,328 shares currently valued at approximately $14.47 million.
The transaction reduced his ownership position by 0.83%, representing a modest trim relative to his substantial overall holdings.
The insider transaction surfaces amid divergent Wall Street perspectives on CRCL. On April 8, Compass Point shifted to a Sell stance, lowering its target from $79 down to $77. This projection suggests potential downside of approximately 18% from prevailing trading levels at that moment.
Margin dynamics drive Compass Point’s pessimism. The research firm anticipates gross margin compression during early 2026, attributable to USDC supply migration toward lower-profitability segments. Circle’s trailing twelve-month gross profit margin registered merely 8.67%.
Profitability Metrics Under Scrutiny
Compass Point’s 2027 EBITDA projection falls 20% beneath consensus Street estimates. The firm attributes the stock’s recent strength to margin expansion hopes—a thesis it now disputes.
The equity currently commands roughly 40 times bullish 2027 EBITDA projections. These forecasts presume USDC momentum rebounds in Q2 2026, an outcome Compass Point questions.
CRCL has declined 37% across the previous six months despite delivering robust revenue expansion approaching 64% during that timeframe. Markets continue grappling with the disconnect between impressive top-line performance and margin constraints.
Bearish views don’t dominate entirely, however. Robert W. Baird elevated its target to $138 during March while maintaining an Outperform stance. Morgan Stanley holds an Equal Weight rating at an $80 target, highlighting regulatory uncertainties surrounding stablecoin legislation.
Wells Fargo reduced its objective from $128 to $111 in February while preserving an Overweight recommendation. Goldman Sachs lifted its target to $88 alongside a Neutral rating. The analyst community’s average target reaches $126.29, with consensus settling at Hold.
Institutional Capital Continues Flowing In
Notwithstanding analyst reservations, institutional investors expanded positions through Q3. Vanguard amplified its stake 61.6%, currently controlling 5.58 million shares valued around $739.6 million.
CloudAlpha Capital Management grew its holdings 181.1% to 283,964 shares. Rheos Capital Works expanded its stake 20.8%, lifting its total to 302,000 shares.
Circle’s latest quarterly performance, disclosed February 25, delivered $0.43 EPS compared to the $0.25 consensus projection. Revenue totaled $770.23 million, representing 76.9% year-over-year growth.
On the product front, Circle introduced the Circle Payments Network Managed Payments service, a stablecoin settlement platform enabling financial institutions to leverage USDC for transactions without direct digital asset management. Triple-A additionally joined the network to facilitate stablecoin-to-fiat conversions for international payouts.
CRCL’s 52-week trading band spans $49.90 to $298.99. The 50-day moving average stands at $87.06 while the 200-day rests at $95.30.


